Task allocation in cancer medication management - Integrating the pharmacist

被引:15
作者
Doehler, Nele
Krolop, Linda
Ringsdorf, Susanne
Meier, Klaus [2 ]
Ko, Yon-Dschun [3 ]
Kuhn, Walther [4 ]
Schwalbe, Oliver
Jaehde, Ulrich [1 ]
机构
[1] Univ Bonn, Inst Pharm, Dept Clin Pharm, D-453121 Bonn, Germany
[2] German Canc Soc DKG, Oncol Pharm Working Grp, Berlin, Germany
[3] Johanniter Hosp Bonn, Dept Internal Med, Bonn, Germany
[4] Univ Hosp Bonn, Dept Obstet & Gynecol, Bonn, Germany
关键词
Medication management; Cancer care; Teamwork; Oncology pharmacist; DRUG-INTERACTIONS; MULTIDISCIPLINARY TEAMS; PHARMACEUTICAL CARE; BREAST-CANCER; ONCOLOGY; INFORMATION; COORDINATION; SERVICES; MEMBERS; WARD;
D O I
10.1016/j.pec.2011.03.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: This study was conducted to define the task allocation in multiprofessional cancer medication management (MCMM) with a special focus on the role of the pharmacist as well as patient education and counseling. The acceptance of the proposed task allocation and the perceptions on multiprofessional teamwork were explored on a national level. Methods: We held local focus group meetings (University of Bonn with collaboration partners) to identify MCMM tasks. With the Delphi technique the tasks were allocated to physicians, pharmacists and nurses. Professionals (members of the German Cancer Society) were approached nationwide via an online questionnaire to evaluate the acceptance of the MCMM model and explore their perceptions on multiprofessional teamwork. Results: The MCMM model comprised 38 tasks including 11 on patient education and counseling. It was rated to be reasonable (79%) and feasible (68%). Barriers and benefits of multiprofessional teamwork stated were patient-, team-, therapy-, structure-, and resources-related. Conclusions: The MCMM model integrates the pharmacist with responsibilities in patient education and counseling as well as prevention of drug-related problems. The approach was generally appreciated nationwide by the professions. Practice implications: The proposed model can serve as a tool to trigger changes in cancer medication management. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:367 / 374
页数:8
相关论文
共 41 条
[1]  
Advisory Council on the Assessment of Developments in the Health Care System, 2007, COOP RESP PRER TARG
[2]   Does the information level of cancer patients correlate with quality of life? A prospective study [J].
Annunziata, MA ;
Foladore, S ;
Magri, MD ;
Crivellari, D ;
Feltrin, A ;
Bidoli, E ;
Veronesi, A .
TUMORI JOURNAL, 1998, 84 (06) :619-623
[3]   Drug interactions in oncology [J].
Beijnen, JH ;
Schellens, JHM .
LANCET ONCOLOGY, 2004, 5 (08) :489-496
[4]   Drug-drug interactions in oncology: Why are they important and can they be minimized? [J].
Blower, P ;
de Wit, R ;
Goodin, S ;
Aapro, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (02) :117-142
[5]  
Bremberg Eva Ramme, 2006, J Oncol Pharm Pract, V12, P75, DOI 10.1177/1078155206070412
[6]  
CARRINGTON C, 2010, J ONCOL PHARM PRACT
[7]   INFORMATION AND PARTICIPATION PREFERENCES AMONG CANCER-PATIENTS [J].
CASSILETH, BR ;
ZUPKIS, RV ;
SUTTONSMITH, K ;
MARCH, V .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) :832-836
[8]   The informational roles and psychological health of members of 10 oncology multidisciplinary teams in the UK [J].
Catt, S ;
Fallowfield, L ;
Jenkins, V ;
Langridge, C ;
Cox, A .
BRITISH JOURNAL OF CANCER, 2005, 93 (10) :1092-1097
[9]  
*DKG, 2009, DAT ENTR FORM ONC CE
[10]  
Farris Karen B, 2005, Res Social Adm Pharm, V1, P369, DOI 10.1016/j.sapharm.2005.06.002